Phenoxymethyl derivatives

US11352330B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11352330-B2
Application numberUS-202016811656-A
CountryUS
Kind codeB2
Filing dateMar 6, 2020
Priority dateSep 4, 2015
Publication dateJun 7, 2022
Grant dateJun 7, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides novel compounds having the general formula (I)wherein RA, RB, RC, RC1 and W are as defined herein, compositions including the compounds and methods of using the compounds.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein: (1) R A is selected from the group consisting of i) C 1 -C 6 -alkyl, ii) cyano-C 1 -C 6 -alkyl, iii) C 3 -C 8 -cycloalkyl, iv) halo-C 1 -C 6 -alkoxy, v) halo-C 1 -C 6 -alkyl, vi) aryl substituted with R G , R G1 and R G2 , vii) heterocycloalkyl substituted with R G , R G1 and R G2 , and viii) heteroaryl substituted with R G , R G1 and R G2 ; and R B is selected from the group consisting of i) C 1 -C 6 -alkyl, ii) C 3 -C 8 -cycloalkyl, iii) C 1 -C 6 -alkylsulfonyl, iv) C 3 -C 8 -cycloalkylsulfonyl, v) C 1 -C 6 -alkylsulfonylamino, vi) C 3 -C 8 -cycloalkylsulfonylamino, vii) aminocarbonyl, ix) halogen, x) halo-C 1 -C 6 -alkoxy, xi) halo-C 1 -C 6 -alkyl, xii) heterocycloalkyl, and xiii) heteroaryl substituted with one H, C 1 -C 6 -alkyl, or trialkylsilyl-C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl; or (2) R A is selected from the group consisting of i) cyano-C 1 -C 6 -alkyl, ii) C 3 -C 8 -cycloalkyl, iii) halo-C 1 -C 6 -alkoxy, iv) halo-C 1 -C 6 -alkyl, v) aryl substituted with R G , R G1 and R G2 , vi) heterocycloalkyl substituted with R G , R G1 and R G2 , and vii) heteroaryl substituted with R G , R G1 and R G2 ; and R B is cyano; and: R C and R C1 are independently selected from the group consisting of i) H, ii) C 1 -C 6 -alkyl, iii) C 3 -C 8 -cycloalkyl, iv) halo-C 1 -C 6 -alkoxy, v) halo-C 1 -C 6 -alkyl, and vi) halogen; or R B and R C together with the carbon atoms to which they are attached form a ring system selected from the group consisting of i) C 3 -C 8 -cycloalkyl substituted with one to two substituent independently selected from H, C 1 -C 6 -alkyl, halo-C 1 -C 6 -alkoxy, halo-C 1 -C 6 -alkyl and C 3 -C 8 -cycloalkyl, ii) heterocycloalkyl substituted with one to two substituent independently selected from H, C 1 -C 6 -alkyl, halo-C 1 -C 6 -alkoxy, halo-C 1 -C 6 -alkyl and C 3 -C 8 -cycloalkyl, iii) aryl substituted with one to two substituent independently selected from H, halogen, C 1 -C 6 -alkyl, halo-C 1 -C 6 -alkoxy, halo-C 1 -C 6 -alkyl and C 3 -C 8 -cycloalkyl, and iv) heteroaryl substituted with one to two substituent independently selected from H, halogen, C 1 -C 6 -alkyl, halo-C 1 -C 6 -alkoxy, halo-C 1 -C 6 -alkyl, and C 3 -C 8 -cycloalkyl; W is ring system A: R D1 is selected from the group consisting of i) H, ii) C 1 -C 6 -alkyl, iii) halo-C 1 -C 6 -alkoxy, iv) halo-C 1 -C 6 -alkyl, and v) C 3 -C 8 -cycloalkyl, R G is selected from the group consisting of i) H, ii) C 1 -C 6 -alkoxy, iii) C 1 -C 6 -alkoxy-C 1 -C 6 -alkylcarbonylamino-C 1 -C 6 -alkyl, iv) C 1 -C 6 -alkoxy-C 1 -C 6 -alkylcarbonyl(C 1 -C 6 -alkyl)amino-C 1 -C 6 -alkyl, v) C 1 -C 6 -alkoxycarbonyl, vi) C 1 -C 6 -alkyl, vii) C 1 -C 6 -alkylsulfonyl, viii) C 3 -C 8 -cyloalkylsulfonyl, ix) carboxy, x) cyano, xi) C 3 -C 8 -cycloalkyl, xii) C 3 -C 8 -cycloalkoxy, xiii) C 3 -C 8 -cycloalkylcarbonylamino-C 1 -C 6 -alkyl, xiv) C 3 -C 8 -cycloalkylcarbonyl(C 1 -C 6 -alkyl)amino-C 1 -C 6 -alkyl, xv) C 1 -C 6 -alkylcarbonylamino-C 1 -C 6 -alkyl, xvi) C 1 -C 6 -alkylcarbonyl(C 1 -C 6 -alkyl)amino-C 1 -C 6 -alkyl, xvii) halo-C 1 -C 6 -alkyl, xviii) halo-C 1 -C 6 -alkoxy, xix) halogen, xx) hydroxy, xxi) aminocarbonyl substituted on the nitrogen atom with RN and Ro, xxii) aminocarbonyl-C 1 -C 6 -alkoxy substituted on the nitrogen atom with RN and Ro, xxiii) heteroaryl substituted with one H, C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl, alkyl, halo-C 1 -C 6 -alkoxy, benzyl or aryl, wherein benzyl and aryl are substituted with one to three substituents independently selected from H, C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl, halo-C 1 -C 6 -alkyl and halo-C 1 -C 6 -alkoxy, xxiv) heterocycloalkyl-C 1 -C 6 -alkoxy substituted with one H, C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl, halo-C 1 -C 6 -alkyl, halo-C 1 -C 6 -alkoxy, benzyl or aryl, wherein benzyl and aryl are substituted with one to three substituents independently selected from H, C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl, halo-C 1 -C 6 -alkyl and halo-C 1 -C 6 -alkoxy, and xxv) heterocycloalkyl-C 1 -C 6 -alkyl substituted with one H, C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl, halo-C 1 -C 6 -alkyl, halo-C 1 -C 6 -alkoxy, benzyl or aryl, wherein benzyl and aryl are substituted with one to three substituents independently selected from H, C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl, halo-C 1 -C 6 -alkyl and halo-C 1 -C 6 -alkoxy; R G1 and R G2 are independently selected from the group consisting of i) H, ii) halogen, iii) C 1 -C 6 -alkyl, iv) C 3 -C 8 -cycloalkyl, v) halo-C 1 -C 6 -alkoxy, and vi) halo-C 1 -C 6 -alkyl; R N is selected from the group consisting of i) H, ii) C 1 -C 6 -alkoxy, iii) C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, iv) C 1 -C 6 -alkoxycarbonyl-C 1 -C 6 -alkyl, v) C 1 -C 6 -alkyl, vi) carboxy-C 1 -C 6 -alkyl, vii) C 3 -C 8 -cycloalkyl, viii) C 3 -C 8 -cycloalkyl-C 1 -C 6 -alkyl, ix) hydroxy-C 1 -C 6 -alkyl, x) phenyl, and xi) heteroaryl-C 1 -C 6 -alkyl; and R O is selected from the group consisting of i) H, and ii) C 1 -C 6 -alkyl; or R N and R O together with the nitrogen atom to which they are attached form a heterocycloalkyl. 2. The compound of claim 1 , wherein the compound is: 3-[(2-tert-butyl-4-chloro-5-methylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(2-tert-butyl-4-chloro-5-fluorophenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(3,3-dimethyl-6-propan-2-yl-1,2-dihydroinden-5-yl)oxymethyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[[2-tert-butyl-4-(3-methyl-1,2,4-oxadiazol-5-yl)phenoxy]methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(2-tert-butyl-4-[1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]phenoxy]methyl-4-methyl-1H-1,2,4-triazol-5-one; 3-[[2-tert-butyl-4-(1-methylimidazol-2-yl)phenoxy]methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[[2-tert-butyl-4-(1,3-oxazol-2-yl)phenoxy]methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(2-tert-butyl-4-morpholin-4-ylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[[2-tert-butyl-4-(3-methylimidazol-4-yl)phenoxy]methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[[2-tert-butyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)phenoxy]methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(4-chloro-2-cyclopropyl-5-methylsulfonylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(2-tert-butyl-4-methylsulfonylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[[2-tert-butyl-4-[3-(2-trimethyl silyl-ethoxymethyl)imidazol-4-yl]phenoxy]-methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(4-chloro-2-cyclopropyl-5-methylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(4-chloro-2-cyclohexyl-5-methylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[[4-chloro-5-methyl-2-(oxan-4-yl)phenoxy]methyl]-4-methyl-1H-1,2,4-triazol-5-one; 2-chloro-4-cyclopropyl-5-[(4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methoxy]benzonitrile; N-[2-chloro-4-cyclopropyl-5-[(4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methoxy]phenyl]methanesulfonamide; 4-tert-butyl-3-[(4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methoxy]benzamide; 4-methyl-3-[(5-methyl-2-propan-2-ylphenoxy)methyl]-1H-1,2,4-triazol-5-one; 3-[(4-chloro-5-methyl-2-propan-2-ylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(4-chloro-2-propan-2-ylphenoxy)methyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(6-cyclopropyl-2-methyl-1,3-benzothiazol-5-yl)oxymethyl]-4-methyl-1H-1,2,4-triazol-5-one; 3-[(4-chloro-2-cyclobutyl-5-methylphenoxy

Assignees

Inventors

Classifications

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • C07D403/12Primary

    linked by a chain containing hetero atoms as chain links · CPC title

  • One oxygen atom attached in position 3 or 5 · CPC title

  • 1,2,4-Triazoles · CPC title

  • with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11352330B2 cover?
The invention provides novel compounds having the general formula (I)wherein RA, RB, RC, RC1 and W are as defined herein, compositions including the compounds and methods of using the compounds.
Who is the assignee on this patent?
Hoffmann La Roche
What technology area does this patent fall under?
Primary CPC classification C07D403/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).